The Global Resource For Connecting Buyers and Sellers

CStone files CS1003, an anti-PD-1 antibody, for clinical trial approval in Australia

SUZHOU, China, Dec. 27, 2017 /PRNewswire/ — CStone Pharmaceuticals (Suzhou) Co., Ltd., (CStone) today announced that a formal application for clinical trial approval has been submitted to Human Research Ethics Committees of the Scientia Clinical Research center in Australia for the…